Artículo
Recent discoveries of antifungal activity in plant antimicrobial peptides
Fecha de publicación:
11/2024
Editorial:
Springer
Revista:
International Journal of Peptide Research and Therapeutics
ISSN:
1573-3904
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Antimicrobial peptides (AMPs) are positive-charged small molecules of less than 50 amino acids, with antibacterial and antifungal properties. The main mechanism ofaction against pathogens is the cell membrane disruption. Particularly in plants, most of the AMPs are cysteine-rich peptides, which allow the formation of numerous disulfide bridges. Disulfide bridges give the AMPs a high chemical, thermal, and proteolytic stability. AMPS of plants are classified into seven families. Each family has distinctive properties, although there are similarities between them, such as their antimicrobial properties, antifungal activity, and common amino acid sequences. Considering that these peptides have been involved in plant defense due to their efficiency and stability, makes them advantageous compared to the current drugs that are more susceptible to generating resistance.This study collected the last 5 years of antifungal studies of three plant AMP families, defensins, thionins and hevein-like peptides, with a special focus on defensins, the most studied family in antifungal activity. These AMPs could be useful for future applications in the agricultural, pharmaceutical and biotechnology industry, which will improve life quality.
Palabras clave:
Antifungal
,
cysteine-rich peptides
,
mode of action
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(NANOBIOTEC)
Articulos de INSTITUTO DE NANOBIOTECNOLOGIA
Articulos de INSTITUTO DE NANOBIOTECNOLOGIA
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Martínez Ceron, María Camila; Vitale, Roxana Gabriela; Giudicessi, Silvana Laura; Recent discoveries of antifungal activity in plant antimicrobial peptides; Springer; International Journal of Peptide Research and Therapeutics; 31; 1; 11-2024; 1-14
Compartir
Altmétricas